Calcitonin therapy in prolonged immobilization hypercalcemia.

Area of Science:

• Pediatric Rehabilitation
• Endocrinology
• Neurosurgery

Background:

• Immobilization hypercalcemia is a potential complication in patients with spinal cord injuries.
• Management of prolonged hypercalcemia presents significant clinical challenges.

Observation:

• An 11-year-old boy with a C4-C5 spinal cord injury experienced persistent hypercalcemia for 131 days during hospitalization.
• Calcitonin treatment showed a variable response, limited by the escape phenomenon.
• Glucocorticoids provided partial efficacy, while other therapies were ineffective.

Findings:

• Increased bone resorption is the primary cause of immobilization hypercalcemia.
• Both calcitonin and glucocorticoids inhibit bone resorption.
• Glucocorticoids can mitigate the escape phenomenon associated with calcitonin therapy.

Implications:

• Combination therapy with calcitonin and glucocorticoids is suggested for severe immobilization hypercalcemia.
• This combined approach leverages the rapid action of calcitonin and the sustained effect of glucocorticoids.
• Optimizing treatment strategies is crucial for managing complex cases of pediatric hypercalcemia post-spinal cord injury.